INS and cardiovascular disorder: Further, with deteriorating transplant-function and frequently existing co-morbidities, like above mentioned cardiovascular disease, therapeutic options are sometimes limited to few oral anti-hyperglycemic agents and anabolic insulin, which might result in an additional worsening of glucose homeostasis due to weight gain.